Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Panic Disorder
NCT00279617Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Jan 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in panic disorder, sponsored by Lindner Center of HOPE. Primary endpoint: Hamilton Anxiety Scale. Started Jan 2006; status: completed.
02
Drugs
levetiracetam
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT00279617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279617.